Zai Lab (ZLAB) Operating Leases (2019 - 2026)
Zai Lab (ZLAB) posted Operating Leases of $12.1 million for Q1 2026, down 9.55% sequentially from $13.4 million in Q4 2025, and down 1.72% YoY from $12.3 million in Q1 2025.
Zai Lab (ZLAB) Operating Leases (2019 - 2026) Analysis & Trends
Zai Lab has reported Operating Leases for 8 years, with the latest figure at $12.1 million in Q1 2026.
- Quarterly Operating Leases fell 1.72% year-over-year to $12.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.1 million (down 1.72% YoY) and the FY2025 annual result came in at $13.4 million, down 2.38% from the prior year.
- Operating Leases eased to $12.1 million in Q1 2026 per ZLAB's latest filing, from $13.4 million in the prior quarter.
- Over five years, Operating Leases peaked at $13.9 million in Q3 2022 and troughed at $5.8 million in Q2 2024.
- A 5-year average of $11.0 million and a median of $11.8 million in 2023 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2024 and 2025: Operating Leases tumbled 50.63% in 2024, then soared 94.85% in 2025.
- Over 5 years, Operating Leases stood at $13.3 million in 2022, then tumbled by 39.69% to $8.0 million in 2023, then jumped by 70.4% to $13.7 million in 2024, then dropped by 2.38% to $13.4 million in 2025, then slipped by 9.55% to $12.1 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $12.1 million, $13.4 million, and $10.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.45 Mn |
| Mar 31, 2026 | 12.11 Mn |
| Dec 31, 2025 | 13.39 Mn |
| Sep 30, 2025 | 10.84 Mn |
| Jun 30, 2025 | 11.31 Mn |
| Mar 31, 2025 | 12.32 Mn |
| Dec 31, 2024 | 13.71 Mn |
| Sep 30, 2024 | 6.11 Mn |
| Jun 30, 2024 | 5.80 Mn |
| Mar 31, 2024 | 7.54 Mn |
| Dec 31, 2023 | 8.05 Mn |
| Sep 30, 2023 | 9.81 Mn |
| Jun 30, 2023 | 11.76 Mn |
| Mar 31, 2023 | 12.98 Mn |
| Dec 31, 2022 | 13.34 Mn |
| Sep 30, 2022 | 13.89 Mn |
| Jun 30, 2022 | 12.96 Mn |
| Mar 31, 2022 | 11.10 Mn |
| Dec 31, 2021 | 9.61 Mn |
| Sep 30, 2021 | 10.65 Mn |